Cambridge Mass. doc leads call for reform of “dysfunctional” pharmaceutical system.

Lead author Adam Gaffney is a pulmonologist and critical care physician at the Cambridge Health Alliance. Here's the summary, from the BMJ: Key messages The US and Canadian pharmaceutical systems are dysfunctional Costs are exorbitant, commercial goals distort drug development, misleading promotion fosters misuse, and medications are too often unaffordable for patients We propose reforms that … Continue reading Cambridge Mass. doc leads call for reform of “dysfunctional” pharmaceutical system.

Advertisements

Covering health care — from DNA to ACA — is a challenge. Three reporters share insights and tips at Harvard Law #healthintheheadlines

See #healthintheheadlines for tweets from Wenesdays panel of three top journalists on the challenge of covering healthcare today https://t.co/AboXfZ2VJU — COM 201 (@CO201) April 5, 2018 #healthintheheadlines is now wrapped up! Look for a recording of the panel on our site in a few days! Thanks to @jrovner @rachanadixit @sangerkatz and @emma_sandoe for joining us! … Continue reading Covering health care — from DNA to ACA — is a challenge. Three reporters share insights and tips at Harvard Law #healthintheheadlines

Boston researcher in NYTimes on why the US spends so much on health care. The answer is same as it was in 2003 — prices.

Austin Frakt,  director of the Partnered Evidence-Based Policy Resource Center at the V.A. Boston Healthcare System writes in The New York Times today: A large part of the answer can be found in the title of a 2003 paper in Health Affairs by the Princeton University health economist Uwe Reinhardt: “It’s the prices, stupid.” He … Continue reading Boston researcher in NYTimes on why the US spends so much on health care. The answer is same as it was in 2003 — prices.

KHN: Medicare Fails To Recover Hundreds Of Millions Of Dollars In Lab Overcharges

By Fred Schulte, Kaiser Health News Used by permission. Note comment from Boston lawyer. Also published by STATnews.  Five years ago, Companion DX Reference Lab hoped to cash in on cutting-edge genetic tests paid for by Medicare. The Houston lab marketed a test to assess how a person’s genes affect tolerance for drugs such as … Continue reading KHN: Medicare Fails To Recover Hundreds Of Millions Of Dollars In Lab Overcharges

Will a legislative study put Massachusetts on the path to single-payer? Supporters head to Beacon Hill to push for it.

Tucked inside the health care bill passed by the state Senate is a provision to study the possibility of a  single-payer health care system. The bill's cost control measures are getting all the attention. From the Globe:   The 100-page bill attempts to help struggling community hospitals by setting a floor for the reimbursements they receive from … Continue reading Will a legislative study put Massachusetts on the path to single-payer? Supporters head to Beacon Hill to push for it.

Health Policy Commission versus Partners

Lots of amazing research and care happens at Partners Healthcare, and we pay a bonus for it. Or, as  Boston Globe writer  Priyanka Dayal McCluskey puts it "Partners has long been criticized for using its power in the health care market to extract higher payments from insurers and driving up health care costs." But, Partners faces scrutiny … Continue reading Health Policy Commission versus Partners

Can hospitals be leaner?@STATnews take you insides the Brigham’s “struggle to cut costs.”

More here. Over the past three months, the Brigham provided STAT un usual access to meetings of its top management and internal deliberations and documents.  This inside look shows how one of the nation’s leading hospitals is confronting the daunting financial and marketplace forces buffeting academic medical centers across the U.S. “This wasn’t about ordinary … Continue reading Can hospitals be leaner?@STATnews take you insides the Brigham’s “struggle to cut costs.”